The photothermal conversion efficiency of TiCN was determined and the Piezo1-specific agonist significantly enhanced the antitumor effect of TiCN, indicating the excellent potential of Piezo1 activation in breast cancer treatment. This evidence concerns the gene PIEZO1 and breast carcinoma.